Calcium Citrate in Fortified-Food Applications
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
How to Fortify Beverages with Calcium by Dr
Ingredients How to Fortify Beverages With Calcium by Dr. Gerhard Gerstner Along with current developments of the overall functional foods market, the use of minerals and especially calcium salts is expected to exhibit strong growth rates. In contrary to other functional ingredients, calcium is widely known as being beneficial for human health and there is no need to explain its nutritional ad- vantages to the customer. According to Leatherhead International, future trends include growing consumer concern regarding osteoporosis and bone health, leading to increased sales of calcium salts. The con- observation is seen as being one of tinuous market growth drives mineral the main factors causing osteo- Common calium sources salt suppliers to offer not only one porosis 2 .As a consequence, national for beverage fortification product but rather a range of different authorities all over the world have calcium salts and granulations to be recently reconsidered recommend- Table 1 shows a typical range of able to tune them to industrial cus- ations in order to take remedial calcium fortified beverages which tomers’ applications. This article measures against calcium deficiency have been seen in European and US discusses important nutritional, and accordingly, to reduce the risk of supermarkets recently. Practically technological as well as economical osteoporosis. In this respect, the US every type of beverage such as aspects of calcium in beverages with National Institute of Health (NIH) has mineral water, soy milk, energy drink, a focus on our company’s products increased the amounts of optimal nectar or juice does have a fortified Tricalcium Citrate, Calcium Gluconate daily calcium intake and defined product line already. -
Calcium Supplements | Memorial Sloan Kettering Cancer Center
PATIENT & CAREGIVER EDUCATION Calcium Supplements This information explains calcium supplements and how to take them. Calcium is a mineral that you need to build and maintain healthy bones. If you don’t get enough calcium from your diet, your body will take it from your bones. This can cause osteoporosis. Osteoporosis Osteoporosis develops when you lose bone tissue, which makes your bones more likely to fracture (break). Osteoporosis is most common in females who have gone through menopause (a permanent end of your monthly periods). It can develop in anyone, including males, due to medication or illness. Some risk factors for osteoporosis include: Having a thin build Being of Northern European or Asian descent Having fair skin Going through menopause early (before the age of 45) Taking certain steroid medications for longer than 3 months Calcium Supplements 1/9 Not getting enough physical activity Not getting enough calcium in your diet (or from dietary supplements) Smoking Drinking too much alcohol (more than 2 drinks per day for females or 3 drinks per day for males) Taking aromatase inhibitors (medications that stop the production of estrogen and are used to treat breast cancer) Vitamin D Vitamin D is a vitamin that helps your body absorb calcium. Your body makes vitamin D after being exposed to the sun. Vitamin D is also found in some foods. It can be hard to get enough vitamin D from just sunlight and foods. Your doctor or clinical dietitian nutritionist might tell you to take vitamin D supplements. These can be prescription or over-the-counter vitamin D supplement pills or calcium supplements with vitamin D added. -
Potassium-Magnesium Citrate Is an Effective Prophylaxis Against Recurrent Calcium Oxalate Nephrolithiasis
0022-5347/97/1586-2069$03.00/0 JOURNAL OF UROLOGY Vol. 158,2069-2073, December 1997 Copyright Q 1997 by AMERICANUROLOGICAL ASS~CIATION, INC. Printed in U.S.A. POTASSIUM-MAGNESIUM CITRATE IS AN EFFECTIVE PROPHYLAXIS AGAINST RECURRENT CALCIUM OXALATE NEPHROLITHIASIS BRUCE ETTINGER,* CHARLES Y. C. PAK, JOHN T. CITRON, CARL THOMAS, BEVERLEY ADAMS-HIJET AND ARLINE VANGESSEL From the Diuision of Research, Kaiser Permanente Medical Care Program, Oakland, California, the Department of Mineral Metabolism, Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, Department of Medicine, Kaiser Permanente Medical Center, Walnut Creek, California, Department of Urology, Kaiser Permanente Medical Center, San Francisco, California, and Kaiser Foundation Research Institute, Kaiser Foundation Hospitals, Oakland, California ABSTRACT Purpose: We examined the efficacy of potassium-magnesium citrate in preventing recurrent calcium oxalate kidney calculi. Materials and Methods: We conducted a prospective double-blind study of 64 patients who were randomly assigned to receive placebo or potassium-magnesium citrate (42 mEq. potassium, 21 mEq. magnesium, and 63 mEq. citrate) daily for up to 3 years. Results. New calculi formed in 63.6%of subjects receiving placebo and in 12.9%of subjects receiving potassium-magnesiumcitrate. When compared with placebo, the relative risk of treat- ment failure for potassium-magnesium citrate was 0.16 (95%confidence interval 0.05 to 0.46). potassium-magnesium citrate had a statistically significant effect (relative risk 0.10,95%confi- dence interval 0.03 to 0.36) even after adjustment for possible confounders, including age, pretreatment calculous event rate and urinary biochemical abnormalities. -
Electro-Activation of Potassium Acetate, Potassium Citrate and Calcium
Liato et al. SpringerPlus (2016) 5:1760 DOI 10.1186/s40064-016-3453-1 RESEARCH Open Access Electro‑activation of potassium acetate, potassium citrate and calcium lactate: impact on solution acidity, Redox potential, vibrational properties of Raman spectra and antibacterial activity on E. coli O157:H7 at ambient temperature Viacheslav Liato1,2, Steve Labrie1,3 and Mohammed Aïder1,2,4* *Correspondence: [email protected] Abstract 1 Institute of Nutrition and Functional Foods (INAF), Aims: To study the electro-activation of potassium acetate, potassium citrate and Université Laval, Quebec, QC calcium lactate aqueous solutions and to evaluate their antimicrobial effect against E. G1V 0A6, Canada coli O157:H7 at ambient temperature. Full list of author information is available at the end of the Methods and results: Potassium acetate, potassium citrate and calcium lactate aque- article ous solutions were electrically excited in the anodic compartment of a four sectional electro-activation reactor. Different properties of the electro-activated solutions were measured such as: solutions acidity (pH and titratable), Redox potential and vibrational properties by Raman spectroscopy. Moreover, the antimicrobial activity of these solu- tions was evaluated against E. coli O157:H7. The results showed a pH decrease from 7.07 0.08, 7.53 0.12 and 6.18 0.1 down to 2.82 0.1, 2.13 0.09 and 2.26 0.15, after ±180 min of electro-activation± ± of potassium acetate,± potassium± citrate and calcium± lactate solution, respectively. These solutions were characterized by high oxidative ORP of 1076 12, 958 11 and 820 14 mV, respectively. -
Reflections on Dentifrice Ingredients, Benefits and Recommendations a Peer-Reviewed Publication Written by Fiona M
Earn 4 CE credits This course was written for dentists, dental hygienists, and assistants. Reflections on Dentifrice Ingredients, Benefits and Recommendations A Peer-Reviewed Publication Written by Fiona M. Collins, BDS, MBA, MA This course has been made possible through an unrestricted educational grant from Colgate-Palmolive, Co. The cost of this CE course is $59.00 for 4 CE credits. Cancellation/Refund Policy: Any participant who is not 100% satisfied with this course can request a full refund by contacting PennWell in writing. Educational Objectives dentifrice use. Recommendations should be based on an The overall goal of this article is to provide dental profession- individual patient’s specific needs and desires as well as the als with information on the active and inactive ingredients in scientific support for a dentifrice. Both the Food and Drug dentifrices and their benefits. Administration (FDA) and the American Dental Associa- Upon completion of this course, the clinician will be able tion (ADA) have played roles in controlling (FDA) and ac- to do the following: cepting (ADA) dentifrices. 1. List active ingredients in dentifrices and their therapeutic benefits. Dentifrice Ingredients 2. List inactive ingredients in dentifrices and their functions. Dentifrices contain both active and inactive ingredients. Ac- 3. Know the roles of the FDA and ADA with respect to tive ingredients are those that offer a therapeutic benefit, while over-the-counter dentifrices. inactive ingredients are non-therapeutic and also contribute 4. Understand the considerations involved and importance of to the physicochemical properties of the dentifrice – its feel, recommending OTC dentifrices for individual patients. -
Innovative Prolonged-Release Oral Alkalising Formulation
www.nature.com/scientificreports OPEN Innovative prolonged‑release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults C. Guittet1, C. Roussel‑Maupetit1, M. A. Manso‑Silván 1, F. Guillaumin1, F. Vandenhende2 & L. A. Granier 1* A multi-particulate fxed-dose combination product, consisting of a combination of two alkalising salts formulated as prolonged-release granules, ADV7103, was developed to obtain a sustained and prolonged alkalising efect. The specifc release of both types of granules was shown in vitro through their dissolution profles, which indicated that potassium citrate was released within the frst 2–3 h and potassium bicarbonate up to 10–12 h after administration. The long-lasting coverage of ADV7103 was confrmed through a randomised, placebo-controlled, double-blind, two-period study, measuring its efect on urine pH in healthy adults (n = 16) at doses of alkalising agent ranging between 0.98 and 2.88 meq/kg/day. A signifcant increase of urine pH with a positive dose–response in healthy adult subjects was shown. Urine pH above 7 was maintained during 24 h with a dosing equivalent to 1.44 meq/kg twice a day, while urine pH was below 6 most of the time with placebo. The efect observed was non-saturating within the range of doses evaluated and the formulation presented a good safety profle. ADV7103 provided an efective prolonged release of alkalising salts to cover a 12-h efect with adequate tolerability and could aford a twice a day (morning and evening) dosing in patients requiring long-term treatment. -
Dietary Supplements Compendium Volume 1
2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs . -
Calcium Chloride
Electrolytes Livestock 1 2 Identification of Petitioned Substance 3 4 Chemical Names (Compiled from commercial 44 Calcium propionate, propanoic acid, calcium salt 5 electrolyte formulations): 45 Ca(CH3.CH2.COO)2 6 Calcium chloride (10043-52-4) 46 Calcium oxide, lime CaO 7 Calcium borogluconate (5743-34-0) 47 Calcium sulfate, gypsum CaSO4 8 Calcium gluconate (299-28-5) 48 9 Calcium hypophosphite (7789-79-9) 49 Magnesium diborogluconate, Mg[(HO.CH2CH 10 Calcium lactate (814-80-2) 50 (HBO3)CH(CH.OH)2 COO]2 11 Calcium phosphate tribasic (7758-87-4) 51 Magnesium citrate, Mg3(C6H5O7)2 12 Calcium phosphate dibasic (7757-93-9) 52 Magnesium hypophosphite Mg(H2PO2)2 13 Calcium phosphate monobasic (10031-30-8) 53 Magnesium sulfate, Epsom salts MgSO4 14 Calcium propionate (4075-81-4) 54 Potassium chloride KCl 15 Calcium oxide (1305-78-8) 55 Potassium citrate, K3(C6H5O7) 16 Calcium sulfate (7778-18-19) 56 Tripotassium phosphate K3(PO4) 17 Magnesium borogluconate (not available) 57 Dipotassium hydrogen phosphate K2HPO4 18 Magnesium citrate, tribasic (3344-18-1) 58 Potassium dihydrogen phosphate KH2PO4 19 Magnesium hypophosphite (10377-57-8) 59 Sodium acetate Na(CH3COO) 20 Magnesium sulfate (7487-88-9) 60 Sodium bicarbonate, baking soda NaHCO3 21 Potassium chloride (7447-40-7) 61 Sodium chloride, table salt, NaCl 22 Potassium citrate (866-84-2) 62 Sodium citrate, trisodium citrate Na3(C6H5O7) 23 Potassium phosphate, tribasic (7778-53-2) 63 Trisodium phosphate Na3(PO4) 24 Potassium phosphate, dibasic (7758-11-4) 64 Disodium hydrogen phosphate Na2HPO4 25 Potassium phosphate, monobasic (7778-77-0) 65 Sodium dihydrogen phosphate NaH2PO4 26 Sodium acetate (127-09-3) 66 27 Sodium bicarbonate (144-55-8) 67 Trade Names: 28 Sodium chloride (7647-14-5) 68 These individual electrolyte salts are not sold 29 Sodium citrate (68-04-2) 69 with Trade Names. -
POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES, USP, 8 Meq 1
174931-1 Front 10" X 10" Fold 1.25" X 1.25" Prints Black 10/14/09 POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES, USP, 8 mEq 1. For the treatment of patients with hypokalemia with or without ic inspection before and after one week of solid oral potassium chlo and 10 mEq metabolic alkalosis, in digitalis intoxications, and in patients with ride therapy. The ability of this model to predict events occurring in hypokalemic familial periodic paralysis. If hypokalemia is the result usual clinical practice is unknown. Trials which approximated usual Only of diuretic therapy, consideration should be given to the use of a clinical practice did not reveal any clear differences between the wax lower dose of diuretic, which may be sufficient without leading to matrix and microencapsulated dosage forms. In contrast, there was DESCRIPTION: hypokalemia. a higher incidence of gastric and duodenal lesions in subjects receiv Potassium Chloride Extended-release Capsules, USP, 8 mEq and 10 mEq ing a high dose of a wax matrix controlled-release formulation under are oral dosage forms of microencapsulated potassium chloride 2. For the prevention of hypokalemia in patients who would be at conditions which did not resemble usual or recommended clinical containing 600 and 750 mg, respectively, of potassium chloride particular risk if hypokalemia were to develop e.g., digitalized practice (i.e., 96 mEq per day in divided doses of potassium chloride USP equivalent to 8 and 10 mEq of potassium. patients or patients with significant cardiac arrhythmias, hepatic cir administered to fasted patients, in the presence of an anticholinergic rhosis with ascites, states of aldosterone excess with normal renal drug to delay gastric emptying). -
Effect of Citrus Fruit (Sudachi) Juice on Absorption of Calcium
Food Sci. Technol. Res., +, (+), ,1ῌ-*, ,**0 E#ect of Citrus Fruit (Sudachi) Juice on Absorption of Calcium from Whole Small Fish in Healthy Young Men +ῌ , , + - . Yoshitaka NII , Takamasa OSAWA , Daisuke KUNII , Kazuhiro FUKUTA , Kentaro SAKAI , Maki KONDO and , Shigeru YAMAMOTO + Food Technology Division, Tokushima Prefectural Industrial Technology Center, ++ῌ, Nishibari, Saika-cho, Tokushima 11*ῌ2*,+, Japan , Department of International Public Health Nutrition, Institute of Health Biosciences, The University of Tokushima Graduate School, -ῌ+2ῌ+/ Kuramoto-cho, Tokushima 11*ῌ2/*-, Japan - Department of Nutrition and Health Promotion, Faculty of Human Life Science, Hiroshima Jogakuin University, .ῌ+-ῌ+ Ushita- Higashi, Higashi-ku, Hiroshima 1-,ῌ**0-, Japan . Faculty of Human Life Science, Shikoku University, +,-ῌ+ Ebisuno, Furukawa, Ojin-cho, Tokushima 11+ῌ++3,, Japan Received July +, ,**/; Accepted January ,/, ,**0 Shirasuboshi (boiled and semi-dried whitebait) is a processed seafood that is abundant in calcium. It is eaten whole and commonly consumed in Japan. In this study, we examined the e#ect of Sudachi (Citrus sudachi Hort. ex. Shirai) juice on calcium, magnesium and phosphorus bioavailability in healthy young men. Dried shirasuboshi powder treated with distilled water (C) or sudachi juice (S,*) was prepared for use in two experimental diets, the control diet and the sudachi diet. Either S,* or C was added to a basal diet with a low calcium content (+2* mg/d). The basal diet and the two experimental diets were each consumed for 0 d by six healthy young men according to a randomized and crossover design. The apparent absorp- tion and retention of calcium, magnesium and phosphorus from shirasuboshi were determined and were found to be significantly higher in the sudachi diet than in the control diet. -
List of Designated Food Additives
The Japan Food chemical Research Faundation List of Designated Food Additives The substances below are the designated food additives appearing in Appended Table 1, as mentioned in Article 12 of the Enforcement Regulations under the Food Sanitation Law. These additives are listed here in alphabetical order. They are 472 in total as of January 15, 2021. The number preceding the name of each additive is the sequence number given to the corresponding additive in the original Japanese table.The names of the substances are translated by the Foundation from the Japanese original. 16 Acesulfame Potassium(Acesulfame K) 20 Acetaldehyde 332 Glacial Acetic Acid 23 Acetone 22 Acetophenone 17 Acetylated Distarch Adipate 19 Acetylated Distarch Phosphate 18 Acetylated Oxidized Starch 5 Adipic Acid 26 Advantame 32 DL-Alanine 196 Aliphatic Higher Alcohols 197 Aliphatic Higher Aldehydes (except those generally recognized as highly toxic) 198 Aliphatic Higher Hydrocarbons (except those generally recognized as highly toxic) 183 Allyl Cyclohexylpropionate 377 Allyl Hexanoate (Allyl Caproate) 55 Allyl Isothiocyanate (Volatile Oil of Mustard) 446 Aluminum Ammonium Sulfate (Crystal: Ammonium Alum, Dried: Burnt Ammonium Alum) 447 Aluminum Potassium Sulfate (Crystal: Alum or Potassium Alum, Dried: Burnt Alum) 29 (3-Amino-3-carboxypropyl)dimethylsulfonium Chloride 45 Ammonia 36 Ammonium Alginate 248 Ammonium Bicarbonate (Ammonium Hydrogen Carbonate) 245 Ammonium Carbonate 85 Ammonium Chloride 463 Ammonium Dihydrogen Phosphate (Ammonium Phosphate, Monobasic) 33 Ammonium -
Nutrition: Beyond Calcium and Vitamin D
Acid Base Balance and Skeletal Health Nutrition: Beyond Calcium and Vitamin D Deborah E. Sellmeyer, MD Professor of Medicine • Acid precursors: sulfur containing amino acids in all proteins Division of Endocrinology, Gerontology, and Metabolism • Base precursors: alkaline potassium salts in fruit/vegetables Stanford University School of Medicine (Kcitrate, KHCO3) • Does exposure to a net dietary acid load mobilize base from bone to titrate dietary acid? Long-term Potential Effects of a Net Dietary Acid Load Relationship is Complex • Skeleton • Primary focus on protein (acid) – Physiochemical effect – Cell mediated • Protein only half the equation: hunter-gatherer diets – ~250 g/d protein • Muscle – typically net base producing – IGF-1 – Mobilization of glutamine • Hunter-gatherer diet = 88 meq/day base • Effects of age-related decline in renal function • Western diet = 58 meq/day acid • ? Net effect = bone / muscle loss Sebastian A et. al. Am J Clin Nutr. 2002 Dec;76(6):1308-16. Page 1 Sulfur-containing AA (g) per 10g Protein Improving Dietary Acid-Base Balance spaghetti noodles • Option 1: Less acid haddock white rice – Reduce dietary protein, cereal grains chicken – Protein important for peak bone mass, english muffin skeletal maintenance, healing ground beef cottage cheese • Option 2: More base milk – Dietary (potassium-rich fruit / veggies) soybeans Grt North beans – Alkaline potassium supplements peanut butter • Potassium bicarbonate peas • Potassium citrate almonds 0.00 0.10 0.20 0.30 0.40 KCitrate and Long-term Calcium Balance